$RDVT

Dubner Derek sold $689K of RDVT

Dubner Derek (Chief Executive Officer) sold 12,000 shares of Red Violet, Inc. (RDVT) at an average of $57.43 ($57.24–$57.62, $0.69M total) across 2 trades on 2026-06-01.

Original reporting
SEC EDGAR · Dubner Derek
Published Jun 1, 2026, 11:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:47 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RDVT
Bearish
medium confidence
Mentioned
$RDVT
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RDVTBearishLow
01

Why it matters

The disclosed sale provides fresh information on insider sentiment, which can affect short‑term price dynamics.

02

Market read

Primary disclosure of a CEO's share sale; modest materiality for traders monitoring insider activity.

03

What to watch

No 10b5‑1 plan was used; the CEO may be diversifying holdings without loss of confidence.

Relevance 5/10Novelty 4/10Timing: after-hours filing on 2026-06-01

Background

SEC Form 4 filings disclose insider transactions; this filing reports a CEO's share sale.

Company-level read

Ticker impact

$RDVTBearishMedium confidence
Context

CEO Derek Dubner sold 12,000 shares for $689,160, reducing his stake to 557,273 shares.

Expected impact

likely downward pressure as the market prices in the insider sell

Evidence & confidence

A $689k sale by the chief executive is material for a mid‑cap company and could trigger short‑term selling.

Market effects

Minimal impact on the broader sector; only relevant to Red Violet investors.

None

None

Counterpoint

The sale could be a routine liquidity event rather than a negative signal.

Key entities

  • Red Violet, Inc.

    Issuer of the shares sold.

  • Dubner Derek

    Chief Executive Officer of Red Violet, filing the insider sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RDVTMed

Red Violet (RDVT) Turns Record Growth Into Real Profit Gains

Red Violet (RDVT) reported Q2 2026 revenue of $26.7M, up 23%, and net income of $5M, nearly doubling. Gross margin increased to 76%, and adjusted EBITDA rose 48% to $11.2M. The company added 447 new customers and 25,493 new users for its FOREWARN product. Red Violet raised $109M in an August offering, bringing cash to $160M with no debt. CEO Derek Dubner highlighted a strong pipeline of initiatives. The company repurchased 74,500 shares at an average price of $41.87.

$RDVTMed

Red Violet, Inc. (RDVT): Record Revenue of $26.7 Million, an Increase of 23%; Record Cash Flow from Operations of $10.6 Million

Red Violet, Inc. (RDVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 red violet Reports Second Quarter 2026 Financial Results Record Revenue of $26.7 Million, an Increase of 23%; Record Cash Flow from Operations of $10.6 Million BOCA RATON, Fla. – August 10, 2026 – Red Violet, Inc. (NASDAQ: RDVT), a leading identity intelligence and a

$RDVTMedAI 8/10

red violet Announces Closing of $115 Million Underwritten Public Offering of Common Stock, Including Full Exercise of Underwriters' Option

Red Violet, Inc. (NASDAQ: RDVT) said it closed an underwritten public offering of 1,916,667 shares of common stock, including 250,000 shares from full exercise of the underwriters’ option. The company estimates net proceeds of about $108.6 million. Proceeds will be used for working capital, general corporate purposes, and potential strategic acquisitions.

$RDVTMedAI 8/10

red violet Announces Pricing of $100 Million Underwritten Public Offering of Common Stock

Red Violet, Inc. (NASDAQ: RDVT) priced an underwritten public offering of 1,666,667 shares of common stock at $60.00 per share, raising expected gross proceeds of $100 million before underwriting fees and expenses. The offering is expected to close Aug. 7, 2026, with a 30-day option for up to 250,000 additional shares. Net proceeds will fund working capital and corporate purposes.